Surveillance After Double Mastectomy for Breast Cancer Recurrence
For patients with a history of double mastectomy, surveillance should consist of regular clinical examinations every 3-6 months for the first 3 years, every 6-12 months for the next 2 years, and annually thereafter, with no routine imaging of the mastectomy site unless the patient is high-risk or symptomatic. 1
Clinical Surveillance Protocol
Physical Examination Schedule
- First 3 years: Every 3-6 months
- Years 4-5: Every 6-12 months
- After 5 years: Annually
Components of Clinical Surveillance
- Detailed cancer-related history
- Thorough physical examination of the chest wall and regional lymph nodes
- Assessment for symptoms of recurrence
Imaging Recommendations
Routine Imaging
- No routine imaging is recommended for the mastectomy site in asymptomatic patients 1
- The American Society of Clinical Oncology (ASCO) specifically recommends against:
- Routine mammography of the mastectomy site
- Routine breast MRI
- Routine ultrasound
- Routine PET/CT scans 1
Special Circumstances for Imaging
High-risk patients:
Symptomatic patients:
- For new symptoms (palpable mass, skin changes, pain), appropriate diagnostic imaging should be performed
- Ultrasound is typically the first-line imaging modality for evaluating symptoms at the mastectomy site 2
Patient Education
Counsel patients about symptoms of recurrence including:
- New lumps or masses on the chest wall
- Skin changes or thickening
- Persistent pain
- Swelling or redness 1
Instruct patients to seek immediate medical attention if any concerning symptoms develop between scheduled follow-up visits 1
Common Pitfalls and Caveats
Overuse of imaging:
- Routine imaging of asymptomatic mastectomy sites provides minimal benefit and may lead to false positives
- The American College of Radiology (ACR) explicitly states there is no evidence to support routine mammography, DBT, or PET/CT for surveillance after mastectomy 1
Misinterpretation of post-surgical changes:
- Fat necrosis is the most common benign finding in the post-operative period and can mimic recurrence 2
- Correlation of clinical, radiological, and pathological findings is essential
Neglecting the psychological aspects:
- Patients with mastectomies may experience anxiety about recurrence
- Regular clinical follow-up provides reassurance and opportunity for education
Special Considerations
Genetic counseling: Offer genetic counseling if hereditary risk factors are suspected (strong family history, age ≤60 with triple-negative breast cancer) 1
Endocrine therapy: Counsel patients on the importance of adherence to adjuvant endocrine therapy if prescribed 1
Contralateral breast: If the patient had a unilateral mastectomy with contralateral breast intact, annual mammography of the remaining breast is recommended 1
By following this surveillance protocol, clinicians can effectively monitor for breast cancer recurrence while avoiding unnecessary imaging and procedures, focusing on the interventions most likely to detect recurrence at an early stage when treatment would be most effective.